Poehling Capital Management’s Chemours CC Stock Holding History

Poehling Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5	Closed	–	–	312
2017 Q4	$0	Buy	+5	New	+$262	﹤0.01%	284

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Poehling Capital Management's CC Position: Q1 2018 in Review

Poehling Capital Management sold out of Chemours (CC) in Q1 2018, closing a stake of 5 shares.

Poehling Capital Management first reported a position in CC in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 546 funds tracked by Wall St. Rank hold CC as of Q1 2018.

Poehling Capital Management reported no remaining Chemours position as of Q1 2018 after selling out during the quarter.
Poehling Capital Management sold 5 Chemours shares in Q1 2018.
Poehling Capital Management first reported a position in Chemours in Q4 2017 and held it in 1 quarter.
Poehling Capital Management's Chemours position peaked at $0 in Q4 2017.
546 funds tracked by Wall St. Rank held Chemours as of Q1 2018.

Based on Poehling Capital Management's 13F filing for Q1 2018, filed 14 May 2018.